Avoid the Carnage, Stick with the Winners 🏆

Follow strong trends right now…                                                                                                                                                                                                                                                                                                                                                                                                                 July 25, 2024 | [Read Online]( Avoid the Carnage, Stick with the Winners 🏆 Follow strong trends right now… You have a problem… You’re not watching us LIVE right now! Monday through Friday our Traders at RagingBull are live streaming and teaching folks just like you how they find some of the best options and stock setups, so why haven’t you joined us? Jump into our [Market Masters live trade room right now]( and take a peek (right now, it’s free!) I hope you have been paying attention to my emails lately.  Not only have there been some great trading opportunities, but my warning on the market this week could have saved you a small fortune. I started pointing out last week that the QQQ was starting to trade under both the 20 day and 20 hour moving averages for the first time in months. As I always say, “Nothing good happens under the 20 moving averages.” Well, if you want to know what I am doing again today I can tell you I am not looking to trade large-cap tech stocks. The markets need time to heal and this is not an ideal environment for me to trade it – so I won’t do it! I continue to see a lot of great opportunities when it comes to smaller momentum stocks, however. Just like Tuesday’s idea, which gained 17%, or Wednesday’s idea that made a 20% move and is up another 10% today in pre-market trading. I am telling you, look where is strength in the market, don’t try and force trades that aren’t working. Today, I’ve got another really great looking stock I want to share with you. Go to your favorite platform and pull up Kindly MD, Inc. (KDLY) right now, and I’ll show you what I am seeing. First of all, KDLY is a recent IPO. It started trading at the end of May, and not a lot of people are following this stock, yet. The trading hasn’t been too exciting so far as it was down nearly 50% from the peak at one point a couple of weeks ago. However, since that low point, the volume has picked up and the stock has been on a tear and is up over 35% since last week. Look at this chart showing the strong move KDLY has made recently...  This is especially significant in the face of a horrendous overall market. That is what I call real strength, and you should pay attention to it. Right now is a crucial moment for KDLY though. As you can see, the stock is now hitting the previous top it made in June. If KDLY can break through that, I think it could act as a new support level, and possibly be the launching pad to a retest of the highs from the IPO day around $4. It not, keep a close eye on the 20-hour moving average (the yellow line on my chart above.) The stock needs to hold above that level in order for the uptrend to stay in tact. So far, it has been moving up perfectly, as you can see. An uptrend like this, against an overall terrible market, is something I think serious traders should be paying attention to. Things are heating up, so make sure KDLY is on the top of your watchlist this morning! As always, I encourage you to spend time learning more about the company. Here are some points I found interesting tp help you get started… Kindly MD, Inc. (KDLY) is a healthcare and healthcare data company that provides comprehensive patient care primarily for patients seeking medical cannabis. The company’s business model combines traditional primary care with behavioral therapy, in addition to prescribing medical cannabis. Right now, KDLY is based in Utah, where it is the largest and highest-rated alternative pain treatment facility in the state… It treats between 1,600 and 1,900 patients per month, and since its founding in 2019, it has served more than 60,000 patient visits. Utah’s medical cannabis program started in 2018, and to date KDLY serves approximately 20% of Utah residents who participate in the program. The company wisely markets its therapies as an alternative to opioids, which were responsible for more than 80,000 overdosing deaths in 2021 alone. But despite all the attention the opioid crisis has received, and all the strict regulations and guidelines that are now in place, the opioid market is still projected to grow 3.5% year-over-year… Any alternative treatments that can put a dent in those numbers should be welcomed. This has been a big year for KDLY… The company went public on the NASDAQ on May 31, and the following month it became Utah’s first alternative medical treatment company to receive credentialing to be contracted under Utah's top insurance payors, including Select Health, Blue Cross Blue Shield, Medicare, and Medicaid, which account for nearly 80% of the population coverage in Utah. Until that point, the company received no insurance reimbursements, so patients were on the hook for all of their costs. KDLY sees several strong near-term drivers for its growth… The biggest, of course, is that prospective patients no longer have to shoulder the full cost of treatment, so long as they have insurance. A second driver is the DOJ’s proposed rescheduling of cannabis — [announced]( in May — from its current Schedule I status to Schedule III. Currently, the DEA classified cannabis as a substance that has "no currently accepted medical use and a high potential for abuse,” whereas this new status would classify it as a substance with "a moderate to low potential for physical and psychological dependence." KDLY thinks this new level of legitimacy will help bring more patients around to the idea of medical cannabis. A third driver will be the extensive data the company has collected, which it is currently categorizing and anonymizing with the goal of monetizing it in 12–18 months. This data will be valuable to other medical providers, to producers of medical cannabis products, and also to the government. Lastly, the company expects to use the proceeds from its IPO to expand its facilities… Right now, KDLY is focused on expanding in Utah, where it still sees significant opportunity for growth, but in the next 12–24 months, it expects to expand to other states, especially conservative states where cannabis is restricted to a medical setting. KDLY brought in $3.7 million in revenue in 2023, but now that it is collecting insurance reimbursements, it has set a goal to add 5,000 new patients in the next 12 months and to achieve $10 million in revenue. Spend time right now doing your own research on the stock, and of course, always approach your trading in a responsible manner. Trading is very risky, and nothing is ever guaranteed, so never trade with more than you can afford to lose. Please read the full disclaimer at the bottom of this email as well so you are aware of additional risks and considerations. Always have a well-thought-out game plan that takes your personal risk tolerance into consideration. Bottom line: When the markets are dicey like they are right now, I think it makes sense to look for strong momentum stocks. Right now, you’ll find that KDLY has been one of the top performers over the last couple of weeks. This is a fast-growing company in a sector that has incredible future potential. It isn’t on the radar of many traders right now, but that is changing quickly. Make sure you look at KDLY right away this morning! To Your Success, P.S. Make sure you join me and over 1000 traders in the [Market Master’s trading room]( today for live trading signals and education. You can access it at no cost right now. *Just so you know, what you're reading is curated content for which we have received a monetary fee (detailed below) to create and distribute. Let's be clear that investing can be quite the roller coaster as stock prices can have wild swings up and down, so consider those crucial risks before you ever consider trading anything we discuss. Make sure you check out our full disclosure down below for the details on how we were paid, the risks, and why these results aren't what you'd call “typical.” Just a quick heads up about this ad you're reading—as we’ve said, even though we like the company referenced above, and all the facts we discussed above are true to the best of our knowledge, we are running a business here. To distribute this information and help offset the costs of maintaining our large digital audience, in advance of writing the content above, we received twenty thousand dollars (cash) from Awareness Consulting Network for advertising Kindly MD, Inc for a one day marketing program on July 25, 2024. This amount was paid by someone else not connected to Kindly MD, Inc. It might be obvious, but whoever paid for this might own shares and is likely looking to sell some or all of them at any time after we send out this information, which might affect the stock price. We may also buy or sell shares in the company at some point in the future, although neither RagingBull nor its owners own any shares of the company at this time. Also, keep in mind that due to the sheer size of our audience, if even a small percentage of people decide they want to buy this stock, it could potentially boost interest enough to hike up those share prices and cause a temporary spike, and the opposite is possible as our program ends, though that is not always the case. Now, diving right into Kindly MD, Inc might sound exciting. But remember, it’s like venturing into the wilderness—be aware that there's exceptional risk involved in trading. This isn't small potatoes we're talking about; you could lose every dime you put in, so always carefully think about what you’re doing. That’s why they call this trading, after all. We're shining a light on the good stuff about the company here, but it's on you to do your homework, make your own calls, and determine a plan for your own trading, hopefully with the help of your professional 1nvestment advis0r. Oh, that brings us to another crucial point—we're not here to tell you (or even recommend) what you should do with your hard-earned money. We’re simply sharing our non-expert thoughts by highlighting some companies we like that could use some help telling their story to more people. We’re obviously biased in our writing. We’re not here to dig into anything that may be negative about the company; this is advertising, after all! Also, keep in mind that if we make some predictions about the future, these are technically known as “forward-L00king statements” under the securities acts, so take those with a grain of salt. As with all forecasts, they’re not set in stone, often wrong, and we certainly can’t know where the Company’s earnings, business, or share price will be tomorrow or a year from now. Everything you read from us is all for your education, information, and possible entertainment. While we believe the info is reliable and accurate, we can't wear a cape and guarantee it. Before you jump into anything, make sure to talk it over with a pro—someone you trust who's licensed to give you real advice. To be clear, Neither Raging Bull nor its owners, employees, or independent contractors are registered as a secur1ties br0ker-dealer, br0ker, 1nvestment advis0r (IA), or IA rep’s with the SEC, any state securities regulat0ry authority, or any self-regulat0ry organization. So, that's the scoop! If you're intrigued and want to learn more about the companies we talk about, hit up the SEC's website to dig into their filings and see the full picture. Questions or concerns about our products? Email Support@ragingbull.com © Copyright 2022, RagingBull [tw]( Update your email preferences or unsubscribe [here]( © 2024 Bright Ideas newsletter 62 Calef Hwy. #233 lee, NH 03861, United States of America [Terms of Service](